India’s Rupee Becomes Worst-Performing Currency of the Year in Asia

The Indian rupee has weakened to around 89.33 per US dollar, making it the worst-performing Asian currency this year after earlier sliding to 88; the INR is down roughly 4.35% year-to-date. The Reserve Bank of India sold more than $30 billion in July to defend the currency (briefly stabilizing near 86), but has not intervened recently as dollar strength (USD up ~20% vs INR over five years, ~6% YTD) and large foreign equity outflows in 2025 pressured the rupee. Ongoing US-India trade uncertainty, higher tariffs and reported corporate appeals to the Modi government add policy risk, increasing the likelihood of further FX volatility and market risk-off positioning for EM assets.

Analysis

Market structure: A weaker INR (89.33 vs USD) mechanically benefits dollar earners — large IT services, pharma and commodity exporters — while hurting net importers (oil refiners, airlines), domestic-consumption plays and rupee-denominated borrowers. RBI’s prior $30bn defence and current non‑intervention signal limited ammo and higher realised volatility; FX-driven margin compression for importers will pressure corporate earnings for the next 1–3 quarters.

Risk assessment: Tail risks include a sudden stop in FII flows forcing emergency capital controls, an aggressive RBI rate hike that spikes local yields, or a rapid trade-deal resolution that re‑strengthens INR; probabilities range 5–20% next 3 months but impact would be high. Immediate (days): elevated FX and equity volatility; short-term (weeks–months): earnings FX translation and higher borrowing costs; long-term (quarters): possible structural current‑account adjustments and reserve depletion.

Trade implications: Direct plays are long USDINR directional exposure (3M) and relative long positions in exporters vs domestic cyclicals; expect 6–12% nominal FX move risk and equity dispersion. Options are valuable — buy USDINR 3M call spreads (eg. 90/94) and INDA (iShares MSCI India ETF) puts 3–6% OTM to hedge systemic downside; reduce duration in INR sovereign bond holdings and consider short 10Y INR futures.

Contrarian view: Consensus underestimates corporate USD debt and the speed of RBI backstops — rupee may overshoot but will likely provoke policy support before sustained freefall. Historical parallels (2013 taper) show sharp drawdowns are often followed by concentrated opportunities in select exporters and fixed‑income once policy clarity arrives; mispricings will appear in ETFs/NDFs for 2–8 weeks.

Key Decisions for Investors

• Establish a 2–3% portfolio position long USDINR via a 3‑month call spread: buy 90 / sell 94 strikes (current 89.33). Size so max loss = 1% portfolio; target >10% payoff if USDINR breaches 92 within 3 months.
• Reduce passive India equity ETF exposure: trim INDA (iShares MSCI India) by 25–40% or buy INDA 3‑month puts ~5% OTM to hedge downside risk; cover if USDINR falls below 87.5 or RBI announces a $10B+ weekly FX intervention.
• Implement a pair trade: go long exporter-heavy names (INFY ~Infosys ADR, 1–2% portfolio) and short a domestic-consumer/retail proxy (e.g., ECOM/retail ETF or NIFTY consumer staples futures, net exposure 0.5–1%). Hold 3–12 months; take profits if INR strengthens above 86.
• Reduce duration in INR sovereign exposure by 30% and initiate a short on 10Y Indian government futures sized to reduce portfolio INR rate sensitivity by ~1% PVBP; unwind if 10Y yields rise >100bps or INR stabilises under 88.
• Monitor near-term catalysts (next 7–30 days): FII flow reports, RBI FX reserve changes (sell >$10–15bn/month), and any US‑India trade headlines. If RBI intervenes with >$20bn within 30 days, pause directional FX trades and reallocate to select long‑equity opportunities.